Lung cancer remains a disease associated with a poor prognosis. Chemoradiotherapy is performed for unresectable stage III non-small cell lung cancer (NSCLC) and inoperable limited-disease small cell lung cancer. In this lecture, chemoradiotherapy for lung cancer is outlined primarily according to the 2014 edition of the Clinical Practice Guidelines for Lung Cancer, and also referring to molecular targeted drugs, radiation pneumonitis, and particle radiotherapy.
|Number of pages||10|
|Journal||Japanese Journal of Clinical Radiology|
|Publication status||Published - 2015|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging